Effect of metformin on prostate cancer outcomes after radical prostatectomy.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Urologic oncology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.urolonc.2013.05.005PMID 23810664PMCID PMC4006350
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metformin and prostate cancer: reduced development of castration-resistant disease and prostate cancer mortality.

  2013cited by this paper
• Re: Daniel E. Spratt, Chi Zhang, Zachary S. Zumsteg, Xin Pei, Zhigang Zhang, Michael J. Zelefsky. Metformin and prostate cancer: reduced development of castration-resistant disease and prostate cancer mortality. Eur Urol 2013;63:709-16.

  2013cited by this paper
• The translational landscape of mTOR signalling steers cancer initiation and metastasis

  2012cited by this paper
• The influence of antidiabetic medications on the development and progression of prostate cancer.

  2012cited by this paper
• Lower Risk of Cancer in Patients on Metformin in ComparisonWith Those on Sulfonylurea Derivatives Results from a large population-based follow-up study

  2011cited by this paper
• TP53 Disruptive Mutations Lead to Head and Neck Cancer Treatment Failure through Inhibition of Radiation-Induced Senescence

  2011influential reference
• Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals

  2011cited by this paper
• Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients.

  2011cited by this paper
• Lower Risk of Cancer in Patients on Metformin in Comparison With Those on Sulfonylurea Derivatives

  2011cited by this paper
• Metformin Inhibits Cell Proliferation, Migration and Invasion by Attenuating CSC Function Mediated by Deregulating miRNAs in Pancreatic Cancer Cells

  2011cited by this paper
• Metformin induces apoptosis of lung cancer cells through activating JNK/p38 MAPK pathway and GADD153.

  2011cited by this paper
• Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

  2010cited by this paper
• Clinical outcomes after radical prostatectomy in diabetic patients treated with metformin.

  2010cited by this paper
• Ionizing radiation activates AMP-activated kinase (AMPK): a target for radiosensitization of human cancer cells.

  2010influential reference
• Association of diabetes with prostate cancer risk in the multiethnic cohort.

  2009cited by this paper
• New Users of Metformin Are at Low Risk of Incident Cancer

  2009cited by this paper
• The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

  2009cited by this paper
• Diabetes mellitus and risk of prostate cancer in the health professionals follow‐up study

  2009cited by this paper
• Metformin use and prostate cancer in Caucasian men: results from a population-based case–control study

  2009cited by this paper
• Cell cycle arrest in Metformin treated breast cancer cells involves activation of AMPK, downregulation of cyclin D1, and requires p27Kip1 or p21Cip1

  2008cited by this paper
• Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model.

  2008cited by this paper
• AMP-Activated Protein Kinase in Metabolic Control and Insulin Signaling

  2007cited by this paper
• LKB1-dependent signaling pathways.

  2006cited by this paper
• Metformin and reduced risk of cancer in diabetic patients

  2005cited by this paper
• AMP-activated protein kinase activators can inhibit the growth of prostate cancer cells by multiple mechanisms.

  2004cited by this paper
• Time-dependent bias was common in survival analyses published in leading clinical journals.

  2004influential reference
• Diabetes mellitus and risk of prostate cancer: a meta-analysis

  2004cited by this paper
• Urologic Oncology: Seminars and Original Investigations - Introduction

  2003cited by this paper

• Is nerve-sparing radical prostatectomy oncological appropriate for all ISUP 2 cancers?

  2025cites this paper
• GLP1 Receptor Agonism Alters Growth and Therapeutic Response in Prostate Cancer.

  2025cites this paper
• Effect of metformin on incidence, recurrence, and mortality in prostate cancer patients: integrating evidence from real-world studies

  2024cites this paper
• Current findings on the antitumor effects of metformin on esophageal squamous cell carcinoma (Review)

  2024cites this paper
• Targeting lipid metabolism in metastatic prostate cancer

  2023cites this paper
• Correlation between metformin intake and prostate cancer

  2023cites this paper
• Post‐diagnostic metformin and statin use and risk of biochemical recurrence in Veterans diagnosed with prostate cancer

  2023cites this paper
• Prognostic value of metformin in cancers: An updated meta-analysis based on 80 cohort studies

  2022cites this paper
• Are Diabetic Patients at Increased Risk for Biochemical Recurrence After Radical Prostatectomy?

  2022cites this paper
• Metformin use and mortality in Asian, diabetic patients with prostate cancer on androgen deprivation therapy: A population‐based study

  2022cites this paper
• The Impact of Metformin Use with Survival Outcomes in Urologic Cancers: A Systematic Review and Meta-Analysis

  2021cites this paper
• EliScholar – A Digital Platform for Scholarly Publishing at Yale

  2021cites this paper
• Effect of Diabetes Mellitus and Metformin Usage on Treatment Outcomes and Side Effects on Prostate Cancer Treated with Radical Radiotherapy

  2021cites this paper
• The Prevention and Control of Cancer by Metformin in Patients with Type 2 Diabetes: A Systematic Mapping Review

  2021cites this paper
• Impact of Concomitant Medications on Biochemical Outcome in Localised Prostate Cancer Treated with Radiotherapy and Androgen Deprivation Therapy.

  2020cites this paper
• Preexisting diabetes, metformin use and long-term survival in patients with prostate cancer

  2020cites this paper
• Pharmacological interventions part IV: Metabolic modifiers

  2020cites this paper
• Metformin may offer no protective effect in men undergoing external beam radiation therapy for prostate cancer

  2019cites this paper
• Statins are Associated With Increased Biochemical Recurrence After Radical Prostatectomy in Diabetic Men but no Association was Seen in Men also Taking Metformin: Results From the SEARCH Database

  2019cites this paper
• The anticancer potential of metformin on prostate cancer

  2019cites this paper
• The effect of metformin therapy on incidence and prognosis in prostate cancer: A systematic review and meta-analysis

  2019cites this paper
• Prostate Cancer Energetics and Biosynthesis.

  2019cites this paper
• Repurposing medicines for the adjuvant treatment of cancer: An evaluation of aspirin and metformin

  2018cites this paper
• Beyond renoprotective impact; ameliorative effects of metformin on malignancies

  2018cites this paper
• The impact of metformin use on the risk of prostate cancer after prostate biopsy in patients with high grade intraepithelial neoplasia

  2018cites this paper
• Antidiabetic drugs influence molecular mechanisms in prostate cancer

  2018cites this paper
• The impact of metformin use on survival in prostate cancer: a systematic review and meta-analysis

  2017cites this paper
• Bioactivity and prostate tissue distribution of metformin in a preprostatectomy prostate cancer cohort

  2017cites this paper
• The Effect of Metformin on Mortality Among Diabetic Cancer Patients: A Systematic Review and Meta-analysis

  2017cites this paper
• The Effect of Metformin and GANT61 Combinations on the Radiosensitivity of Prostate Cancer Cells

  2017cites this paper
• An update of research evidence on nutrition and prostate cancer.

  2017cites this paper
• A spatiotemporal hypothesis for the regulation, role, and targeting of AMPK in prostate cancer

  2017cites this paper
• Combination Therapeutic Strategies Targeting Growth and Metabolic Pathways in Prostate Cancer

  2016cites this paper
• Metformin: A potential chemosensitizing agent for improving castration-resistant prostate cancer treatment

  2016cites this paper
• Metformin Synergistically Enhances Cisplatin-Induced Cytotoxicity in Esophageal Squamous Cancer Cells under Glucose-Deprivation Conditions

  2016cites this paper
• Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis

  2016influential citation
• Dissecting the Dual Role of AMPK in Cancer: From Experimental to Human Studies

  2015cites this paper
• Metformin and prostate cancer mortality: a meta-analysis

  2015cites this paper
• Uso de ácido acetilsalicílico, metformina e estatinas e o cancro da próstata: impacto sobre as características patológicas e risco de recidiva bioquímica

  2015cites this paper
• Metformin effects on biochemical recurrence and metabolic signaling in the prostate

  2015cites this paper
• Association between metformin therapy and incidence, recurrence and mortality of prostate cancer: evidence from a meta‐analysis

  2015cites this paper
• Impact of metformin use on survival in locally-advanced, inoperable non-small cell lung cancer treated with definitive chemoradiation.

  2015cites this paper
• Obesity and cancer: mechanistic insights from transdisciplinary studies.

  2015cites this paper
• Esophageal Adenocarcinoma: The Influence of Medications Used to Treat Comorbidities on Cancer Prognosis.

  2015cites this paper
• Metformin association with lower prostate cancer recurrence in type 2 diabetes: a systematic review and meta-analysis.

  2015cites this paper
• Impact of metformin on clinical outcomes among men with prostate cancer: a systematic review and meta-analysis

  2015cites this paper
• Nutrition, dietary interventions and prostate cancer: the latest evidence

  2015cites this paper
• The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta‐analysis

  2014cites this paper
• TheEffect ofMetforminonMortality FollowingCancer among Patients with Diabetes

  2014cites this paper
• Association of diabetes mellitus and metformin use with biochemical recurrence in patients treated with radical prostatectomy for prostate cancer

  2014influential citation
• Metformin Impacts the Prognosis of Cancer Patients with Type 2 Diabetes

  2014cites this paper
• The Effect of Metformin on Mortality Following Cancer among Patients with Diabetes

  2014cites this paper
• Involvement of metformin and AMPK in the radioresponse and prognosis of luminal versus basal-like breast cancer treated with radiotherapy

  2014cites this paper
• Commonly used diabetes and cardiovascular medications and cancer recurrence and cancer-specific mortality: a review of the literature

  2014cites this paper
• Effect of Metformin on Cancer Risk and Treatment Outcome of Prostate Cancer: A Meta-Analysis of Epidemiological Observational Studies

  2014cites this paper
• Effects of metformin on retinoblastoma growth in vitro and in vivo

  2014cites this paper
• Metformin does not affect risk of biochemical recurrence following radical prostatectomy: results from the SEARCH database

  2013cites this paper
• Metformin is associated with survival benefit in cancer patients with concurrent type 2 diabetes: a systematic review and meta-analysis.

  2013cites this paper